Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Return on Sales (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Return on Sales for 3 consecutive years, with 41.95% as the latest value for Q4 2022.

  • On a quarterly basis, Return on Sales fell 3862.0% to 41.95% in Q4 2022 year-over-year; TTM through Dec 2022 was 41.95%, a 3862.0% decrease, with the full-year FY2022 number at 41.3%, down 3858.0% from a year prior.
  • Return on Sales was 41.95% for Q4 2022 at SELLAS Life Sciences, up from 44.12% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.39% in Q1 2021 to a low of 44.12% in Q3 2022.
  • A 3-year average of 17.43% and a median of 3.33% in 2021 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: plummeted -114bps in 2021, then tumbled -4225bps in 2022.
  • SELLAS Life Sciences' Return on Sales stood at 2.19% in 2020, then tumbled by -52bps to 3.33% in 2021, then plummeted by -1160bps to 41.95% in 2022.
  • Per Business Quant, the three most recent readings for SLS's Return on Sales are 41.95% (Q4 2022), 44.12% (Q3 2022), and 43.95% (Q2 2022).